Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females
Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females have?
Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females has 14 citations in the OpenAlex counts ScholarIQ stores.
When was Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females published?
Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females has 2025 year in the ScholarIQ index.
What is the open-access status of Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females?
Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females has gold oa status in the ScholarIQ index.
What is the DOI of Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females?
The DOI for Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females is on the source record.
What is the PMID of Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females?
The PMID for Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females is on the source record.
What is the OpenAlex record for Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females?
The OpenAlex for Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females is on the source record.